TruDiagnostic – Introduction To Epigenetic Methylation Biomarker

Ageing is the number one risk factor for all chronic disease and death. For years, scientists have tried to find a way to quantify the ageing process so they can effectively find ways to slow ageing. Due to breakthroughs with the new Epigenetic biomarker of DNA methylation, this is now possible. Recent research has described highly predictive and accurate algorithms to quantify Biological age, the instantaneous rate of ageing, Immune age, and more by just analysing this biomarker. In this recorded lecture, Ryan talks about the implication of this biomarker and how to best use it to reduce the biggest risk factors in your patients.

What is Covered:

  • Learn about epigenetic methylation, how it is informing us on how to slow ageing, and the other robust implications it will have across medicine.

More Information

Course By

Ryan Smith

Ryan Smith attended Transylvania University and graduated with a degree in Biochemistry. After finishing all the educational curriculum and passing USMLE Step 1 he decided to leave and open up a pharmacy in the United States that focused on peptide synthesis and formulations for pharmaceutical preparations. That pharmacy, Tailor Made Compounding, became the 4th fastest growing company in healthcare in the US. During that time Ryan invested in several businesses in the functional medicine space. Ryan exited Tailor Made in late 2020. Since then, Ryan has opened many businesses including TruDiagnostic, a company focusing on methylation array-based diagnostics for life extension and preventive healthcare. TruDiagnostic is a CLIA certified lab and health data company focused on serving integrative and functional medicine providers in the United States. TruDiagnostic has a commitment to research with over 30 approved clinical research studies investigating the epigenetic methylation changes of a variety of longevity and health interventions. Since Tru Diagnostic’s inception, they have created one of the largest private epigenetic health databases in the world with over 15,000 patients tested and continue to lead the space in epigenetic methylation interpretation and diagnostic prediction.